Browsing: FLT3CD3

Support

Novel FLT3/CD3 T-Cell Engager Earns Orphan Drug Designation in R/R AML

By NewsCancerMay 20, 20260

The FDA has granted orphan drug designation to the investigational T-cell engager CLN-049 as a treatment for patients with relapsed/refractory…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.